9 AI firms revolutionising healthcare

Picture this: it’s 2043 and headlines across the globe are focussed on a huge medical breakthrough – the first successful remote heart transplant. This groundbreaking procedure, the reports read, was made possible through artificial intelligence (AI) and robotics, allowing a surgeon in New York to remotely operate on a patient in another country.

Sounds like science fiction, right? Perhaps not. We may not be all the way there yet, but there are certainly huge leaps being made in medical science, robotics and AI, allowing this scenario to become a reality sooner than we may think.

AI may currently be making waves in the way we communicate, but it’s also having a huge impact across medicine. Let’s dive into the companies leading the charge.

Medical diagnostics

AI has shown promise in medical diagnostics by analysing vast amounts of patient data and identifying patterns that human physicians may overlook. AI-powered diagnostic tools can aid in detecting diseases like cancer, diabetes and cardiac issues at an early stage, potentially improving patient outcomes.

Some companies we have our eye on in this space are:

Incepto Medical

Founded: 2018
HQ: Paris, France
Incepto Medical's AI platform helps radiologists interpret medical imaging with greater accuracy and speed. With the use of deep learning algorithms, the platform’s AI helps detect anomalies and lets professionals know which results are less favourable and need more attention.

Idoven

Founded: 2018
HQ: Madrid, Spain
Idoven is at the very forefront of AI technology in health and cardiovascular care, advancing early detection and precision medicine for disorders and diseases of the heart and blood vessels.

Healthily

Founded: 2013
HQ: London, UK
Healthily is an AI self-care platform that combines responsive AI with trusted insights and tools, and matches a patient's needs to the latest information from doctors and healthcare specialists, allowing a greater understanding of symptoms.

Drug discovery and development

AI can significantly speed up drug discovery processes by predicting how new compounds might interact with biological systems. This can lead to more efficient drug development, potentially reducing costs and time required to bring new medicines to market.

Some companies we have our eye on in this space are:

Healx

Founded: 2014
HQ: Cambridge, UK
Healx is pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.

BenevolentAI

Founded: 2013
HQ: London, UK
BenevolentAI uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

Exscientia

Founded: 2012
HQ: Oxford, UK
Exscientia combines the latest AI techniques with experimental innovation to engineer a new set of processes for drug discovery.

Operational efficiency

AI can enhance operational efficiency in healthcare settings by automating administrative tasks, optimising resource allocation and predicting patient admission rates. This can help healthcare providers manage their facilities more effectively and allocate resources where they are needed most.

Some companies we have our eye on in this space are:

Proximie

Founded: 2016
HQ: London, UK
Proximie brings together telepresence, content management and data insights to enable surgeons to improve patient safety and share information and expertise.

Corti

Founded: 2016
HQ: Copenhagen, Denmark
Corti is an operational and diagnostic tool, offering a voice-based AI platform for analysing patient interviews. This supports clinicians to make faster and more accurate decisions.

X Lab

Founded: 2006
HQ: Leeds, UK
X Lab facilitates smoother, more efficient communication between different lab systems, all through a single interface.

In summary

While AI arguably permeates most corners of modern life, public acceptance is still in its infancy, especially in a healthcare setting.

Patient privacy ranks as one of the most prevalent concerns of AI in medicine, but with regulation and security a high priority for most governments – take the EU's AI Act for example – we could be looking at a more solid framework from which to build public perception and trust.

And while we’re not yet in a position to let AI take full control of our health system, learning to embrace how it can improve efficiency, accuracy and patient safety can only benefit us.

At Superscript, we're experts in building bespoke insurance solutions for complex tech companies – including medtech and AI – and we're seeing first hand the impact technology is having on this 25,000-year-old industry.